ask="3.40"
ask_size="1000"
average_daily_volume="3230110"
bid="3.38"
bid_size="200"
book_value="-1.75"
change="-0.27"
change_from_200_day_moving_average="-1.93"
change_from_50_day_moving_average="-1.70"
change_from_52_week_high="-5.62"
change_From_52_week_low="0.10"
change_in_percent="-7.36%"
close="3.40"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.37"
ebitda="-120.56M"
eps_estimate_current_year="-1.16"
eps_estimate_next_quarter="-0.10"
eps_estimate_next_year="-0.24"
ex_dividend_date="N/A"
float_shares="122562000"
high="3.59"
high_52_weeks="9.02"
last_trade_date="1/10/2017"
last_trade_price="3.40"
last_trade_size="163476"
last_trade_time="4:00pm"
low="3.30"
low_52_weeks="3.30"
market_capitalization="440.69M"
moving_average_200_day="5.33"
moving_average_50_day="5.10"
name="Merrimack Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="9.67"
open="3.59"
pe_ratio="N/A"
peg_ratio="-0.59"
percent_change_from_200_day_moving_average="-36.20%"
percent_change_from_50_day_moving_average="-33.38%"
percent_change_from_52_week_high="-62.29%"
percent_change_from_52_week_low="+3.03%"
previous_close="3.67"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="4.55"
revenue="104.45M"
shares_outstanding="129615000"
short_ratio="17.94"
stock_exchange="NGM"
symbol="MACK"
volume="13854204"
weeks_range_52="3.30 - 9.02"
